Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
837
mi
from 43215
Fargo, ND
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
837
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
Altru Health Systems
885
mi
from 43215
Grand Forks, ND
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
Altru Health Systems
885
mi
from 43215
Grand Forks, ND
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital Oncology Program
124
mi
from 43215
Toledo, OH
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
124
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinical and Medical Center
344
mi
from 43215
Danville, PA
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinical and Medical Center
344
mi
from 43215
Danville, PA
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
747
mi
from 43215
Sioux Falls, SD
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Jonsson Comprehensive Cancer Center at UCLA
1982
mi
from 43215
Los Angeles, CA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Jonsson Comprehensive Cancer Center at UCLA
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
UCSF Cancer Center and Cancer Research Institute
2109
mi
from 43215
San Francisco, CA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
UCSF Cancer Center and Cancer Research Institute
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Morton Plant Mease Health Care
830
mi
from 43215
Clearwater, FL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Morton Plant Mease Health Care
830
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Lakeland Regional Medical Center
825
mi
from 43215
Lakeland, FL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Lakeland Regional Medical Center
825
mi
from 43215
Lakeland, FL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
University of Chicago Cancer Research Center
270
mi
from 43215
Chicago, IL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
University of Chicago Cancer Research Center
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Lutheran General Hospital
287
mi
from 43215
Park Ridge, IL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Lutheran General Hospital
287
mi
from 43215
Park Ridge, IL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Indiana University Cancer Center
167
mi
from 43215
Indianapolis, IN
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Indiana University Cancer Center
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Holden Comprehensive Cancer Center
460
mi
from 43215
Iowa City, IA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Holden Comprehensive Cancer Center
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Veterans Affairs Medical Center - Iowa City
461
mi
from 43215
Iowa City, IA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Veterans Affairs Medical Center - Iowa City
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
343
mi
from 43215
Baltimore, MD
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Massachusetts General Hospital Cancer Center
643
mi
from 43215
Boston, MA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Massachusetts General Hospital Cancer Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
William Beaumont Hospital
176
mi
from 43215
Royal Oak, MI
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
William Beaumont Hospital
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Barnes Jewish Hospital
397
mi
from 43215
Saint Louis, MO
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Barnes Jewish Hospital
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Duke Comprehensive Cancer Center
354
mi
from 43215
Durham, NC
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Duke Comprehensive Cancer Center
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Westmoreland Hospital
185
mi
from 43215
Greensburg, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Westmoreland Hospital
185
mi
from 43215
Greensburg, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Jameson Memorial Hospital
254
mi
from 43215
New Castle, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Jameson Memorial Hospital
254
mi
from 43215
New Castle, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Allegheny General Hospital
162
mi
from 43215
Pittsburgh, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Allegheny General Hospital
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Western Pennsylvania Cancer Institute
165
mi
from 43215
Pittsburgh, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Western Pennsylvania Cancer Institute
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Latter Day Saints Hospital
1513
mi
from 43215
Salt Lake City, UT
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Latter Day Saints Hospital
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Massey Cancer Center
344
mi
from 43215
Richmond, VA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Massey Cancer Center
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
1644
mi
from 43215
Scottsdale, AZ
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Illinois Oncology Research Association
349
mi
from 43215
Peoria, IL
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Illinois Oncology Research Association
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
274
mi
from 43215
Urbana, IL
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
469
mi
from 43215
Cedar Rapids, IA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
469
mi
from 43215
Cedar Rapids, IA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
565
mi
from 43215
Des Moines, IA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
565
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
715
mi
from 43215
Sioux City, IA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
715
mi
from 43215
Sioux City, IA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
783
mi
from 43215
Wichita, KA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
783
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Duluth
655
mi
from 43215
Duluth, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
655
mi
from 43215
Duluth, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic Cancer Center
559
mi
from 43215
Rochester, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CentraCare Clinic
685
mi
from 43215
Saint Cloud, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CentraCare Clinic
685
mi
from 43215
Saint Cloud, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Metro-Minnesota
627
mi
from 43215
Saint Louis Park, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Metro-Minnesota
627
mi
from 43215
Saint Louis Park, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Missouri Valley Cancer Consortium
685
mi
from 43215
Omaha, NE
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
685
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
837
mi
from 43215
Fargo, ND
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
837
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital Oncology Program
124
mi
from 43215
Toledo, OH
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
124
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinic and Medical Center
344
mi
from 43215
Danville, PA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinic and Medical Center
344
mi
from 43215
Danville, PA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
747
mi
from 43215
Sioux Falls, SD
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/12/2016
Veterans Affairs Medical Center - Birmingham
492
mi
from 43215
Birmingham, AL
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/12/2016
Veterans Affairs Medical Center - Birmingham
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/12/2016
University of California San Diego Cancer Center
1926
mi
from 43215
La Jolla, CA
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/12/2016
University of California San Diego Cancer Center
1926
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/12/2016
UCSF Cancer Center and Cancer Research Institute
2109
mi
from 43215
San Francisco, CA
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/12/2016
UCSF Cancer Center and Cancer Research Institute
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials